Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Alpert Medical School, Brown University Division of General Internal Medicine, Providence, RI, USA.
J Urban Health. 2022 Aug;99(4):723-732. doi: 10.1007/s11524-022-00647-1. Epub 2022 May 24.
Intervetions are urgently needed to reduce the trajectory of the US opioid overdose epidemic, yet implementation is often hampered by resistance or opposition from key community stakeholders. While businesses are economically and physically impacted by the opioid epidemic, they are rarely engaged in efforts to reduce its impact. The establishment of overdose prevention sites (OPS) is being discussed throughout many US jurisdictions with limited attention to the potential positive role of businesses in that process. We surveyed business owners and employees of businesses located in neighborhoods with concentrated drug markets. The study's primary aim was to examine their attitudes to locally-placed OPS. An iterative, two-phase sampling strategy was used to identify recruitment zones. In person (December 2019-March 2020) and telephone-based (April-July 2020) surveys were administered to distinct business owners and employees (N = 149). Sixty-five percent of participants supported OPS in their neighborhood and 47% had recently witnessed an overdose in or around their workplace. While 70% had heard of naloxone, and 38% reported having it on the premises. Correlates of supporting an OPS locally included living in the same neighborhood as work (adjusted odds ratio (aOR) 1.99, 95% confidence intervals (CI): 1.30-3.05); having a more positive attitude towards people who use drugs (aOR 1.33, 95% CI: 1.13-1.58); and having recently seen an overdose in/around the workplace (aOR 2.86, 95% CI: 1.11-7.32). Lack of support being an owner (aOR 0.35, 95% CI: 0.15-0.83). These data indicate the extent to which businesses are directly impacted by the opioid epidemic and the power of personal experience in shaping OPS support in advocacy efforts.
需要采取干预措施来减少美国阿片类药物过量流行的轨迹，但实施工作经常因关键社区利益相关者的抵制或反对而受阻。虽然企业受到阿片类药物流行的经济和身体影响，但它们很少参与减少其影响的努力。在美国的许多司法管辖区，都在讨论建立过量预防场所 (OPS)，但很少关注企业在这一过程中可能发挥的积极作用。我们调查了位于毒品集中市场附近的企业的企业主和员工。该研究的主要目的是调查他们对当地 OPS 的态度。采用迭代、两阶段抽样策略来确定招募区域。对不同的企业主和员工（N=149）进行了现场（2019 年 12 月至 2020 年 3 月）和电话（2020 年 4 月至 7 月）调查。65%的参与者支持他们所在社区的 OPS，47%的人最近在工作场所或周围目睹了过量用药。虽然 70%的人听说过纳洛酮，38%的人报告在工作场所内有纳洛酮。支持当地 OPS 的因素包括与工作场所同处一个社区（调整后的优势比 (aOR) 1.99，95%置信区间 (CI)：1.30-3.05）；对使用毒品的人有更积极的态度（aOR 1.33，95% CI：1.13-1.58）；以及最近在工作场所内/周围目睹过过量用药（aOR 2.86，95% CI：1.11-7.32）。不支持的因素是企业主（aOR 0.35，95% CI：0.15-0.83）。这些数据表明了企业受到阿片类药物流行的直接影响程度，以及个人经历在倡导工作中塑造 OPS 支持的力量。
